Value proposition development for a phase 3 neuroscience asset

• Life Sciences
• Infographics

Navigating payer challenges in rare disease

Navigating payer challenges for rare disease treatments requires innovative approaches to evidence generation and pricing strategies. Our Life Sciences...

• Market Research in Life Sciences
• CRA Insights

Access solutions: Reconciling potential for improved patient access with implementation realities

Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical...

• Rare Disease
• Speaking Engagement

• April 28 - May 1, 2024
• Las Vegas, NV

Asembia: AXS24 Summit

CRA is exhibiting at the conference at booth #2018. Matt Majewski presents his session titled “What is a Fair Price for a Rare Disease Therapy?”...

• Life Sciences
• Sponsorship

• April 30, 2024
• New York, NY

HBA New York - ENDing the Pain Gap: Rewriting the Narrative of Women and Chronic Pain

HBA New York Tri-State presents an engaging evening continuing the discussion of the intersection of Health Equity & Women’s Global Health. How chronic pain...